DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea flag South Korea · Delayed Price · Currency is KRW
25,600
-2,900 (-10.18%)
Apr 10, 2026, 3:30 PM KST

DongKook Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,154,835767,269726,357710,431729,658958,073
Market Cap Growth
74.29%5.63%2.24%-2.63%-23.84%-25.47%
Enterprise Value
1,203,969823,082792,360751,610743,265932,778
Last Close Price
25600.0017150.0016330.3315783.3816031.8620834.20
PE Ratio
17.3611.6211.9515.1913.7919.03
Forward PE
13.5910.6911.0111.6611.6415.82
PS Ratio
1.250.830.890.971.101.61
PB Ratio
1.511.001.071.181.311.90
P/TBV Ratio
1.831.221.271.331.482.14
P/FCF Ratio
44.3429.4614.8893.28--
P/OCF Ratio
16.8011.169.5517.0017.8421.46
EV/Sales Ratio
1.300.890.981.031.121.57
EV/EBITDA Ratio
9.676.427.328.548.0211.58
EV/EBIT Ratio
12.988.539.9211.2410.1114.76
EV/FCF Ratio
46.2331.6016.2498.69--
Debt / Equity Ratio
0.100.100.120.130.120.19
Debt / EBITDA Ratio
0.590.590.740.870.721.22
Debt / FCF Ratio
2.932.931.6510.07--
Net Debt / Equity Ratio
-0.07-0.07-0.01-0.03-0.07-0.14
Net Debt / EBITDA Ratio
-0.40-0.40-0.09-0.20-0.44-0.89
Net Debt / FCF Ratio
-1.95-1.95-0.21-2.295.8211.34
Asset Turnover
0.920.920.910.910.870.84
Inventory Turnover
2.542.542.452.482.532.69
Quick Ratio
1.391.391.261.341.491.40
Current Ratio
2.112.112.022.062.221.91
Return on Equity (ROE)
10.25%10.25%9.72%8.42%10.33%11.03%
Return on Assets (ROA)
5.98%5.98%5.57%5.20%6.05%5.59%
Return on Invested Capital (ROIC)
10.90%11.15%9.36%9.75%12.39%12.30%
Return on Capital Employed (ROCE)
12.10%12.10%11.10%10.50%12.40%11.90%
Earnings Yield
5.72%8.61%8.43%6.64%7.25%5.25%
FCF Yield
2.26%3.40%6.72%1.07%-0.96%-0.66%
Dividend Yield
0.70%1.17%----
Payout Ratio
14.00%14.00%13.58%17.07%15.22%15.99%
Buyback Yield / Dilution
-0.05%-0.05%-0.01%-0.02%-0.01%-
Total Shareholder Return
0.67%1.12%-0.01%-0.02%-0.01%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.